JESSICA ALTMAN, MD
Hematology & Oncology Physician · CHICAGO, IL
Individual Active NPI 1831391200
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 300 | 51,104 | $5,075,336 | $1,476,351 | $1,173,632 |
| 2023 | 400 | 91,173 | $11,331,815 | $2,865,191 | $2,279,438 |
| 2022 | 407 | 91,519 | $8,836,375 | $2,369,507 | $1,887,486 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 4,500 | $50 | $40 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 4,250 | $0 | $0 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,070 | $47 | $37 |
| J1453 | Injection, fosaprepitant, 1 mg | 2,400 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,190 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 318 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 300 | $1 | $1 |
| J9190 | Injection, fluorouracil, 500 mg | 228 | $3 | $2 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 173 | $17 | $13 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 165 | $186 | $141 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 151 | $81 | $65 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 149 | $128 | $95 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 036111034 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Illinois
- NPI 1871239582
- NPI 1629603139
- NPI 1033798905
- NPI 1285995266
- NPI 1407899198
- NPI 1467846360
- NPI 1881156289
- NPI 1831295211
See all Hematology & Oncology Physician providers in Illinois →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.